Asr Vermogensbeheer N.V. Charles River Laboratories International, Inc. Transaction History
Asr Vermogensbeheer N.V.
- $6.75 Trillion
- Q1 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 1,539 shares of CRL stock, worth $183,818. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,539Holding current value
$183,818% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
685Shares Held
50.6MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.11MShares$729 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$608 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$261 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$216 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$212 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.08B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...